CryoPort, Inc. (NASDAQ:CYRX) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of CryoPort, Inc. (NASDAQ:CYRX) have received an average rating of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $12.8333.

Several equities research analysts have weighed in on CYRX shares. UBS Group increased their target price on CryoPort from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Finally, Needham & Company LLC lifted their price objective on shares of CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th.

CryoPort Trading Up 0.7%

CryoPort stock opened at $9.51 on Friday. CryoPort has a 1 year low of $4.58 and a 1 year high of $11.45. The firm’s 50-day moving average is $9.93 and its 200-day moving average is $9.27. The company has a debt-to-equity ratio of 0.40, a quick ratio of 15.01 and a current ratio of 15.77. The company has a market cap of $476.17 million, a P/E ratio of 8.13 and a beta of 1.54.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.05. The firm had revenue of $44.23 million for the quarter, compared to analyst estimates of $41.22 million. CryoPort had a net margin of 35.57% and a negative return on equity of 11.07%. On average, equities analysts expect that CryoPort will post -0.99 earnings per share for the current year.

Insider Buying and Selling at CryoPort

In other news, Director Ramkumar Mandalam sold 11,570 shares of CryoPort stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total transaction of $115,584.30. Following the sale, the director owned 80,758 shares of the company’s stock, valued at approximately $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 10.00% of the company’s stock.

Institutional Trading of CryoPort

Several hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC boosted its position in CryoPort by 299.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 3,639 shares of the company’s stock worth $27,000 after acquiring an additional 2,729 shares during the period. Whittier Trust Co. of Nevada Inc. acquired a new stake in CryoPort in the third quarter worth about $53,000. Tower Research Capital LLC TRC grew its position in CryoPort by 300.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after buying an additional 4,375 shares in the last quarter. AlphaQuest LLC bought a new position in CryoPort in the 3rd quarter valued at about $79,000. Finally, ProShare Advisors LLC acquired a new position in CryoPort during the 2nd quarter valued at about $75,000. Institutional investors own 92.90% of the company’s stock.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.